Related Experiment Video
Updated: Jul 4, 2026

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Clinical significance of intercellular adhesion molecule-1 in ulcerative colitis
Nami Ogawa1, Noboru Saito, Shingo Kameoka
1Department of Surgery II, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. ogawanami@surg2.twmu.ac.jp
Insights
Intercellular adhesion molecule-1 (ICAM-1) shows higher expression in ulcerative colitis (UC) tissue but lower serum levels in UC patients. Its levels correlate with disease severity, but further research is needed on influencing factors.
Area of Science:
- Gastroenterology
- Immunology
- Biomarker Research
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Intercellular adhesion molecule-1 (ICAM-1) plays a role in immune cell adhesion and inflammation.
Purpose of the Study:
- To investigate the clinical significance of ICAM-1 in ulcerative colitis.
- To assess ICAM-1 expression in UC tissues and serum.
- To correlate ICAM-1 levels with disease characteristics.
Main Methods:
- Comparative analysis of ICAM-1 expression in 53 UC cases and 43 controls.
- Measurement of serum ICAM-1 concentrations.
- Evaluation of ICAM-1 levels in relation to clinical severity, activity, and affected range.
Main Results:
- Higher ICAM-1 expression was observed in UC tissue specimens compared to controls.
- Serum ICAM-1 concentrations were significantly lower in the UC group (P = 0.0081).
- Serum ICAM-1 levels varied with clinical severity, disease activity, and affected range.
Conclusions:
- ICAM-1 exhibits distinct dynamics in UC, with increased tissue expression and decreased serum levels.
- Serum ICAM-1 levels may serve as a potential indicator, but require further investigation regarding influencing factors like disease status and treatment.
Abstract:
This study was conducted to assess the clinical significance of intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis (UC). The subjects were 53 cases of UC and 43 control cases. ICAM-1 was expressed to a greater degree in the UC specimens. Serum ICAM-1 concentrations in the UC group showed values that were lower than those in the control group (P = 0.0081). Serum ICAM-1 concentrations were found to vary according to degree of clinical severity, activity, and affected range. Considering the cases of surgery, there was only one case in which a lowering of early postoperative values was found. In all cases in which therapeutic drugs including steroids were not administered, late postoperative values were significantly increased. ICAM-1 dynamics in UC were frequently seen in tissue and exhibited a significantly low value in blood serum; however, the influence of clinical severity, activity, diseased area, measuring time, and therapeutic drugs need further study.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction
